Company news

Amneal Pharmaceuticals, Inc. news in 2020

Amneal Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Amneal Receives Abbreviated New Drug Application Approval for Acyclovir Cream, 5%

November 10, 2020

Amneal Reports Third Quarter 2020 Financial Results

November 5, 2020

Amneal to Report Third Quarter 2020 Results on November 6, 2020

October 14, 2020

Amneal & PL Developments Launch Store Brand Program of Over-the-Counter (“OTC”) Diclofenac Sodium Topical Gel, 1%

October 7, 2020

Amneal Receives Abbreviated New Drug Application Approval for Lidocaine Patch, 5%

August 24, 2020

Amneal Reports Second Quarter 2020 Financial Results

August 5, 2020

Amneal Launches Generic Fluphenazine Following ANDA Approval by FDA

July 9, 2020

Amneal to Report Second Quarter 2020 Results on August 6, 2020

July 7, 2020

Amneal Reports First Quarter 2020 Financial Results

May 10, 2020

Amneal to Report First Quarter 2020 Results on May 11, 2020

April 23, 2020

Amneal Launches Generic Butrans® Following ANDA Approval by FDA

April 15, 2020

Amneal Pharmaceuticals Moving to a Virtual Meeting Format for 2020 Annual Meeting of Stockholders

April 14, 2020

Amneal Accelerates Distribution and Production of Hydroxychloroquine Sulfate to Meet Potential Needs of COVID-19 Patients Nationwide

March 19, 2020

Amneal Pharmaceuticals Appoints Tasos Konidaris as Senior Vice President, Chief Financial Officer

March 10, 2020

Amneal Reports Fourth Quarter and Full Year 2019 Financial Results

February 25, 2020

Amneal to Report Fourth Quarter and Full Year 2019 Results on February 26, 2020

January 23, 2020

Calls in 2020

Decks in 2020